Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Hensman Moss DJ, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ.

Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.

PMID:
28642124
2.

Botulinum toxin-A injections vs radiotherapy for drooling in ALS.

Weikamp JG, Schinagl DA, Verstappen CC, Schelhaas HJ, de Swart BJ, Kalf JG.

Acta Neurol Scand. 2016 Sep;134(3):224-31. doi: 10.1111/ane.12559. Epub 2016 Jan 25.

PMID:
26803950
3.

The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.

Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network, Nguyen HP.

PLoS One. 2013 Jul 22;8(7):e68951. doi: 10.1371/journal.pone.0068951. Print 2013.

4.

Physiotherapy in degenerative cerebellar ataxias: utilisation, patient satisfaction, and professional expertise.

Fonteyn EM, Keus SH, Verstappen CC, van de Warrenburg BP.

Cerebellum. 2013 Dec;12(6):841-7. doi: 10.1007/s12311-013-0495-6.

PMID:
23733611
5.

The effectiveness of allied health care in patients with ataxia: a systematic review.

Fonteyn EM, Keus SH, Verstappen CC, Schöls L, de Groot IJ, van de Warrenburg BP.

J Neurol. 2014 Feb;261(2):251-8. doi: 10.1007/s00415-013-6910-6. Epub 2013 Apr 16. Review.

PMID:
23589192
6.

β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.

Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; Registry investigators of the European Huntington's Disease Network.

J Huntingtons Dis. 2013;2(1):107-24. doi: 10.3233/JHD-130002.

PMID:
25057107
7.

Prospective analysis of falls in dominant ataxias.

Fonteyn EM, Schmitz-Hübsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, Bunn L, Giunti P, Globas C, Klockgether T, Melegh B, Pandolfo M, Schöls L, Timmann D, van de Warrenburg BP.

Eur Neurol. 2013;69(1):53-7. doi: 10.1159/000342907. Epub 2012 Nov 7.

PMID:
23146840
8.

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington's Disease Network, Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF; COHORT study of the HSG.

Neurology. 2012 Mar 6;78(10):690-5. doi: 10.1212/WNL.0b013e318249f683. Epub 2012 Feb 8.

9.

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network, Arning L.

PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247.

10.

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Dürr A, Marelli C, Globas C, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hübsch T, Fancellu R, Mariotti C, Tomasello C, Baliko L, Melegh B, Filla A, Rinaldi C, van de Warrenburg BP, Verstappen CC, Szymanski S, Berciano J, Infante J, Timmann D, Boesch S, Hering S, Depondt C, Pandolfo M, Kang JS, Ratzka S, Schulz J, Tezenas du Montcel S, Klockgether T.

Neurology. 2011 Sep 13;77(11):1035-41. doi: 10.1212/WNL.0b013e31822e7ca0. Epub 2011 Aug 10.

11.

Discrepancies in reporting the CAG repeat lengths for Huntington's disease.

Quarrell OW, Handley O, O'Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB; European Huntington’s Disease Network.

Eur J Hum Genet. 2012 Jan;20(1):20-6. doi: 10.1038/ejhg.2011.136. Epub 2011 Aug 3.

12.

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12. doi: 10.1136/jnnp.2010.209668. Epub 2010 Nov 19. No abstract available.

PMID:
21097549
13.

Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study.

Fonteyn EM, Schmitz-Hübsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, Bunn L, Charles P, Dürr A, Filla A, Giunti P, Globas C, Klockgether T, Melegh B, Pandolfo M, De Rosa A, Schöls L, Timmann D, Munneke M, Kremer BP, van de Warrenburg BP.

Cerebellum. 2010 Jun;9(2):232-9. doi: 10.1007/s12311-010-0155-z.

PMID:
20157791
14.

A throbbing pain in the head: trastuzumab-induced migraine.

van Rooij FG, Dorresteijn LD, Van Bokhoven MM, Verstappen CC.

Anticancer Res. 2009 Oct;29(10):4223-5.

15.

Recent advances in functional neuroimaging of gait.

Bakker M, Verstappen CC, Bloem BR, Toni I.

J Neural Transm (Vienna). 2007;114(10):1323-31. Epub 2007 Jul 12. Review.

16.

Assessing the interplay between cognition and gait in the clinical setting.

Snijders AH, Verstappen CC, Munneke M, Bloem BR.

J Neural Transm (Vienna). 2007;114(10):1315-21. Epub 2007 Jul 6. Review.

PMID:
17612789
17.

Too hot to handle: heat stroke in multiple system atrophy.

Verstappen CC, Bloem BR.

J Neurol. 2007 May;254(5):664-5. Epub 2007 Apr 3. No abstract available.

18.

Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.

Verstappen CC, Bloem BR, Haaxma CA, Oyen WJ, Horstink MW.

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):502-7. Epub 2006 Oct 20.

PMID:
17053905
19.

Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.

Verstappen CC, Koeppen S, Heimans JJ, Huijgens PC, Scheulen ME, Strumberg D, Kiburg B, Postma TJ.

Neurology. 2005 Mar 22;64(6):1076-7.

PMID:
15781834
20.

Dumbbell trigeminal schwannoma in a child: complete removal by a one-stage pterional surgical approach.

Verstappen CC, Beems T, Erasmus CE, van Lindert EJ.

Childs Nerv Syst. 2005 Nov;21(11):1008-11. Epub 2005 Mar 16.

PMID:
15770515

Supplemental Content

Loading ...
Support Center